Cable Hill Partners’s Axsome Therapeutics AXSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-1,000
Closed -$6K 890
2017
Q4
$6K Hold
1,000
﹤0.01% 687
2017
Q3
$6K Buy
+1,000
New +$5.37K ﹤0.01% 702

Other funds holding AXSM

Cable Hill Partners's AXSM Position: Q1 2018 in Review

Cable Hill Partners sold out of Axsome Therapeutics (AXSM) in Q1 2018, closing a stake of 1,000 shares — an estimated $6K sold.

Cable Hill Partners first reported a position in AXSM in Q3 2017 and held it in 2 quarters. The position peaked at $6K in Q4 2017. 36 funds tracked by Wall St. Rank hold AXSM as of Q1 2018.

  • Cable Hill Partners reported no remaining Axsome Therapeutics position as of Q1 2018 after selling out during the quarter.
  • Cable Hill Partners sold 1,000 Axsome Therapeutics shares in Q1 2018, an estimated $6K.
  • Cable Hill Partners first reported a position in Axsome Therapeutics in Q3 2017 and held it in 2 quarters.
  • Cable Hill Partners's Axsome Therapeutics position peaked at $6K in Q4 2017.
  • 36 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2018.

Based on Cable Hill Partners's 13F filing for Q1 2018, filed 20 Apr 2018.